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Abstract 
Background: Methicillin-Resistant Staphylococcus aureus (MRSA) has been an important cause of 
bone infection since the 1940s. Current guidelines recommend targeted antibiotic use for 
osteomyelitis treatment informed by microbial sensitivity patterns. However, in settings without 
microbiology facilities, empirical antibiotic use is common. Unrecognized antibiotic resistance 
potentiates persistence of MRSA with osteomyelitis progression to chronic forms with complications 
despite antibiotic treatment. 
Materials and Methods: A prospective observational study was done to identify common etiological 
agent (s) in bone infection in Melanesian children (that were admitted to the two surgical and one 
pediatric wards of the SJNM-KUGH in the Simbu province of Papua New Guinea in 2012 and 2017), 
observe for presence of antimicrobial resistance, and determine effective antibiotic regimes for 
treatment of bone pediatric osteomyelitis. Seventy pediatric patients presenting from the community 
with osteomyelitis were recruited, with bone and non-bone specimens sampled, cultured and isolates 
tested for resistance to common antibiotics.  
Results: Staphylococcus aureus (S. aureus) was isolated in 67% (47/70) of collected specimens. Of 
the 47 isolates, there was 91.5% resistance to penicillin, 85.1% resistance to methicillin, 89.4% 
resistance to oxacillin, 93.6% resistance to ampicillin and 80.9% resistance to ceftriaxone. S. aureus 
showed 91.5% sensitivity to gentamycin, 93.6% sensitivity to erythromycin, tetracycline and 
clindamycin, and 95.7% sensitivity to Co-trimoxazole. 
Conclusion: MRSA was the leading cause of haematogenous osteomyelitis in Melanesian children. 
S.aureus was isolated mainly from infected long bones of the lower limbs (79%) of children 
presenting from the community, suggesting a predominantly community-associated MRSA.  
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1- INTRODUCTION 
     Staphylococcal resistance to penicillin 
has been recognized in the mid-1940s soon 
after its discovery and introduction into 
treatment regimens (1). Emergence of 
methicillin-resistant Staphylococcus 
aureus has since been reported over the 
years, initially in health care facilities and 
later increasingly in communities (1-8) in 
the Americas, Europe, Asia and the Pacific 
(1-6, 9-11).Current treatment guidelines 
therefore recommend a targeted antibiotic 
use (oral or parenteral) for bone and soft 
tissue infections informed by microbial 
culture and antimicrobial sensitivity 
pattern of isolates (12-15),with 
Ciprofloxacin and clindamycin as drugs of 
choice for the first line treatment of 
suspected Methicillin-resistant S. aureus 
(MRSA) osteomyelitis over traditional 
methicillin-based regimes (12).  
However, in resource-constrained settings 
without the capacity to culture and 
determine microbial sensitivity pattern of 
isolates, empirical antibiotic use is 
common with doctors relying on local 
treatment guidelines and clinical 
experience to guide antibiotic choice (16-
18). In such settings, methicillin 
(cloxacillin, flucloxacillin), and 
chloramphenicol are commonly 
recommended and used widely for a 
generic treatment of pediatric 
osteomyelitis, septic arthritis and 
pyomyositis (19-22).  
Unrecognized antibiotic resistance allows 
for persistence and hypervirulent of 
staphylococcus aureus or MRSA with 
progression of osteomyelitis to chronic 
forms with disabling complications 
including growth plate arrest, shortening or 
angular deformity of the limb, pathological 
fracture, avascular necrosis and septicemia 
despite antibiotic treatment (23-25). At the 
Sir Joseph Nombri Memorial-Kundiawa 
General Hospital in the Central Highlands 
of Papua New Guinea, a high incidence 
and prevalence of osteomyelitis with 
significant Disability-adjusted-life-
years lost (DALYs) lost to disease 
complications was observed in children 
treated routinely with flucloxacillin  and 
chloramphenicol between 2009 and 2015 
(26). This study was therefore done to: 1) 
identify the common etiological agent (s) 
in bone and associated joint or soft tissue 
infections in Melanesian children, 2) 
observe for presence of antimicrobial 
resistance by isolate (s) to commonly used 
antibiotics for osteomyelitis treatment, and 
3) determine an effective, local and age-
specific antibiotic regime for treatment of 
osteomyelitis in children in the region. 
 
2- MATERIALS AND METHODS 
2-1. Method      
      A prospective observational study was 
conducted in 2012 and 2017 on 70 
pediatric patients admitted to the two 
surgical and one pediatric wards of the 
SJNM-KUGH in the Simbu province of 
Papua New Guinea. Study subjects were 
Melanesian children of both sexes ≤ 13 
years of age who presented from the 
community with a clinical and/or 
radiological diagnosis of osteomyelitis 
with no history of a preceding deep-skin or 
soft tissue infection, trauma or surgery. 
The study included cases presenting 
directly from the community with no 
preceding antibiotic treatment and those in 
the ward for two days or less on antibiotic 
treatment; and with a localized pus 
collection, discharging sinus or associated 
septic arthritis. A clinical diagnosis of 
osteomyelitis was made in a child 
presenting with a painful, swollen limb 
with limited mobility, fever (temperature ≥ 
37.5
o
C), and local tenderness with warmth 
or redness (22, 27-29). A radiological 
diagnosis, usually in subacute to chronic 
disease, was made by the presence of 
periosteal elevation or thickening, 
osteolytic changes (sequestration) or 
pathological fractures (22, 28). All surgical 
registrars and consultants in the two 
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surgical and one pediatric wards of the 
hospital participated in identifying study 
subjects while two designated surgical 
registrars enrolled them and collected 
samples from infection sites for microbial 
culture and antimicrobial-sensitivity 
analysis. Pus and blood from 
subperiosteal, intracortical, intramedullary 
or surrounding soft tissue collections, bone 
curetting, and associated-joint aspirates 
were sampled for analyses during 
therapeutic surgical procedures including 
incision and drainage, bone curettage, 
sequestrectomy and bone drilling. Pus 
swabs or blood collected from infection 
sites were stored and transported in Aimes 
transport media or culture bottles, 
respectively. Specimen collected were 
packed into a cool box and transported by 
road to the PNGIMR microbiology 
laboratory 200 kilometers (2 hours’ drive) 
from the hospital. If not delivered on the 
same day as collection, specimen in Aimes 
transport media were stored at 2 to 8 
o
C in 
refrigerator whilst those in culture bottles 
were stored in room temperature (37
o
C). 
On arrival, specimen were streaked onto 
blood agar, chocolate agar and 
MacConkey agar plates for incubation. 
After 24 hours of aerobic incubation at 
37ºC, any growth colonies present were 
identified using standard bacteriological 
methods. All isolates were initially 
identified by Gram stain, catalase and 
oxidase. Staphylococcus aureus was 
confirmed by DNase and coagulase tests. 
Enterobacteriaceae (Proteus spp., 
Escherichia coli and Klebsiella spp.) 
and Pseudomonas were confirmed by 
colony morphology, lactose fermentation, 
motility, IMViC test, triple sugar iron agar 
reaction, and urease production. Clinically 
significant isolates were tested for 
antimicrobial susceptibility using disk 
diffusion methods according to CLSI 
(2012a) guidelines. Rresults were entered 
into an excel spread sheet and analyzed 
using tables and graphs. 
2-2. Ethics Approval 
Ethics consideration and approval was 
granted by the Papua New Guinea Institute 
of Medical Research (PNGIMR) for this 
study. 
3- RESULT 
 
    
 
Table-1 and Fig.1 showing types of specimen sampled from infected bones. 
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Table-2 and Fig.2 show bones and joints that were collected from specimens. 
 
 
 
 
 
 
Table-3 and Fig.3 show bacterial isolates from specimen cultures. 
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Fig.4: Compound graph shows antibiotic sensitivity of S. aureus isolated from collected specimen.  
 
 72% (50/70) of collected specimen were pus 
and blood from infected bones and soft tissue 
or joint, while 20% (14/70) were curetting with 
blood from infected bone. 
 49% (34/70) of specimen were collected from 
infected long bones of the leg (tibia/fibula) 
while 30% (21/70) were from the right and left 
femurs, totaling to 79% (55/70) of sampled 
specimens being from long bones of the lower 
limbs. 
 Coagulase-positive Staphylococcus aureus was 
isolated in 67% (47/70) of the collected 
specimens with no organism grown in 19% 
(13/70) of specimens.  
 Of the 47 Staphylococcus aureus isolates, 
91.5% (43/47) were resistant to penicillin, 
85.1% (40/47) were resistant to methicillin, 
89.4% (42/47) were resistant to oxacillin, 
93.6% (44/47) were resistant to ampicillin and 
80.9% (38/47) were resistant to ceftriaxone. 
 Staphylococcus aureus isolates showed 91.5% 
(43/47) sensitivity to gentamycin, 93.6% 
(44/47) sensitivity to erythromycin, 
tetracycline and chloramphenicol, and 95.7% 
(45/47) sensitivity to co-trimoxazole. 
 Sensitivity to ciprofloxacillin was not tested 
for. 
 
 
4- DISCUSSION 
     The most common isolate from infected 
bone, joint and soft tissue specimens in 
this study was coagulase-positive and 
methicillin-resistant staphylococcus aureus 
(67%). This observed etiological 
predominance is consistent with results 
from similar culture studies on pediatric 
and adult osteomyelitis throughout the 
world (12, 30, 31). MRSA was isolated 
mainly from pus and blood sampled from 
subperiostic, intracortical, intramedullary 
or surrounding soft tissue collections 
mostly along long bones of the lower 
limbs. The high vascularity of growing 
long bones in children is suggested to 
predispose them to hematogenous bacterial 
exposure and infection (32-34). 
Predominant metaphyseal infection of the 
long bones is consistent with proposed 
mechanisms of bone infection including 
metaphyseal sluggish blood flow, paucity 
of immune cells and adherence potential of 
Staphylococcus aureus to metaphysical 
cartilage, with either a 
subperiosteal, medullary, or articular 
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progression and suppuration (23). Non-
bone specimen like pus and blood may be 
less sensitive in ascertaining etiology of 
osteomyelitis than bone culture as 
indicated by a recent study that showed a 
false positive rate of 36% for non-bone 
culture and a lower concordance (38%) 
between bone and non-bone culture for 
staphylococcus aureus (35). However, the 
need for infection control measures to limit 
extension of superficial infections to the 
bone by contiguity, break interpersonal 
transmission chains and minimize 
emergence potential for MRSA is of far 
greater clinical importance (8, 23, 36). 
Hypervirulent MRSA remains an 
important cause of severe forms of 
infections including pediatric osteomyelitis 
in developing countries (8).  
There was 91.5% penicillin resistance and 
81.5% methicillin resistance by the 
Staphylococcus aureus isolates. Most of 
the study subjects presented directly from 
the community with no prior antibiotic 
treatment in the preceding days, indicating 
a largely community-associated MRSA 
(37). Whole genome sequencing with 
relevant spatiotemporal analyses would be 
necessary to provide information on the 
molecular epidemiology of the successful 
clone (s) of MRSA strains (38, 39), which 
can then be correlated with clinical 
epidemiological data to explore 
provenance of MRSA as either community 
or hospital associated, and thereby inform 
infection control interventions and 
therapeutic efforts (8, 36).  
The potential community-associated 
MRSA observed in this study may be 
attributable to imprudent drug distribution 
and use by unsanctioned drug providers, 
suboptimal self-medication, and unguided 
overuse, underuse or misuse of 
antimicrobial agents by rural clinicians 
without adequate diagnostic support to 
inform pathogen susceptibility patterns 
(16, 40). Limited availability and 
affordability of drugs with an increasing 
use of counterfeit, substandard or expired 
drugs in developing countries also 
contributes to emergence potential of 
antimicrobial resistance (41-44). 
Staphylococcus aureus in this study also 
demonstrated a high level of resistance to 
ceftriaxone besides penicillins, which is an 
important third-generation cephalosporin 
commonly used together with penicillins 
for empirical treatment of pediatric 
osteomyelitis and other severe gram-
positive infections in resource-constrained 
settings. This suggests possible presence of 
a multidrug resistant MRSA, genotypically 
related or unrelated to previously 
recognized strains in the community or 
hospital (38, 39, 45), and suboptimal 
efficacy of local penicillin-based regimes 
employed routinely for treatment of 
pediatric osteomyelitis in low-resource 
settings without the capacity to test and 
determine microbial susceptibility patterns. 
Staphylococcus aureus was sensitive to 
Co-trimoxazole, erythromycin, gentamycin 
and chloramphenicol which can alternately 
be used in safe and affordable regimes, 
together with surgery, for effective 
treatment of pediatric osteomyelitis in 
Melanesian children (15, 46).  
Given the general etiological similarity 
between the pediatric and adult 
populations, similar antibiotic regimes can 
also be used for treatment of 
staphylococcal osteomyelitis in 
Melanesian adults as well (47). Changing 
environmental conditions during storage 
and transport of specimens may have 
potentially affected organism survival and 
in turn culture results as suggested by a 
19% no-growth result. This could also be 
due to sterile specimen sampled from 
patients already on an alternate effective 
antibiotic treatment for 24 to 48 hours.  
4-1. Limitations of the study 
The microbial culture and sensitivity-
testing facility being about 200km from 
the hospital posed a logistical challenge for 
optimal specimen storage and transport by 
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road between the hospital and testing 
facility, which inevitably affected the 
number of samples suitable for testing. 
4-2. Recommendation 
 Safe and affordable antibiotic 
regimes based on isolate sensitivity 
patterns should be used together with 
surgery for effective treatment of 
osteomyelitis in Melanesian children, as 
well as adults. Erythromycin, co-
trimoxazole, gentamycin, tetracycline and 
chloramphenicol can be used in regimes 
deemed appropriate for empirical 
treatment of pediatric osteomyelitis in 
settings without microbial culture and 
antimicrobial-sensitivity testing facilities. 
 The need for microbial culture and 
antibiotic sensitivity-testing facilities in 
provincial hospitals or regional health 
facilities to inform antibiotic use in 
developing countries like Papua New 
Guinea cannot be over emphasized. 
 Appropriate policy and funding by 
governments and relevant health 
authorities in the region is necessary to 
build diagnostic capacity towards 
informing antibiotic use and effective 
treatment of osteomyelitis in order to 
reduce the high burden of disease in the 
region. 
 Whole genome sequencing and 
spatio-temporal analyses of MRSA isolates 
is necessary for information on provenance 
and epidemiological patterns of MRSA to 
inform infection control interventions and 
therapeutic responses in the community 
and hospital. 
5- CONCLUSION 
     This study demonstrated coagulase-
positive methicillin-resistant 
staphylococcus aureus to be the leading 
cause (67%) of hematogenous 
osteomyelitis in Melanesian children. 
Staphylococcus aureus was isolated mainly 
from pus and blood (72%) collected from 
infected long bones of the lower limbs 
(79%). Children in the study presented 
largely from the community, indicating a 
predominantly community-associated 
MRSA. Of the 47 staphylococcus aureus 
isolates, 91.5% were penicillin resistant, 
85.1% methicillin resistant, 89.4% 
oxacillin resistant, 93.6% ampicillin 
resistant and 80.9% ceftriaxone resistant, 
indicating presence of a potential 
multidrug resistant MRSA strain. The 
staphylococcal isolates demonstrated more 
than 91% sensitivity to chloramphenicol, 
tetracycline, co-trimoxazole, gentamycin 
and erythromycin, which could alternately 
be used in antibiotic regimes, together with 
surgery, for effective treatment of pediatric 
osteomyelitis to reduce the high burden of 
disease in the region. 
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